Lung Cancer Research and Clinical Trials
Getting lung cancer treatment at City of Hope means you are steps away from labs where exciting new therapies for lung cancer are being developed. That means the new and award-winning lung cancer research we are conducting moves quickly from the lab to our patients’ bedside.
City of Hope patients have access to a wide variety of lung cancer clinical trials such as the newest immunotherapy treatment and targeted therapy approaches — all with the goal of helping extend life.
IMMUNOTHERAPY
TARGETED THERAPY
SMALL CELL LUNG CANCER
- NCT04560972: LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer
- NCT03319940: Phase I study in SCLC: Study Evaluating Safety, Tolerability and PK of AMG 757 in Adults with SCLC
- NCT02864992: Phase II in Non small Cell Lung Cancer (NSCLC) Harboring MET Alterations (VISION)
NON SMALL CELL LUNG CANCER
To refer a patient to one of our clinical trials, please call 626-218-1133. For more information on our clinical trials, please visit: cityofhope.org/clinical-trials.